Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components (Tables)

v3.20.1
Balance Sheet Components (Tables)
 12 Months Ended
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Components of Accrued Liabilities

Accrued liabilities comprise the following (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Accrued liabilities:

 

 

 

 

 

 

 

 

General and administrative

 

$

4,521

 

 

$

297

 

Clinical trial related costs

 

 

1,383

 

 

 

598

 

Non-clinical research and manufacturing operations

 

 

5,774

 

 

 

2,644

 

Payroll related

 

 

2,849

 

 

 

1,787

 

Other accrued expenses

 

 

17

 

 

 

31

 

Total accrued liabilities

 

$

14,544

 

 

$

5,357